nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An oral B subunit: whole cell vaccine against cholera
|
Holmgren, J. |
|
1992 |
10 |
13 |
p. 911-914 4 p. |
artikel |
2 |
Availability of quality vaccines: policies of a non-government organization
|
Poore, Peter |
|
1992 |
10 |
13 |
p. 958-960 3 p. |
artikel |
3 |
Availability of quality vaccines: The industrial point of view
|
Vandersmissen, Walter |
|
1992 |
10 |
13 |
p. 955-957 3 p. |
artikel |
4 |
Availability of vaccines of an assured quality
|
Magrath, D.I. |
|
1992 |
10 |
13 |
p. 952-953 2 p. |
artikel |
5 |
Benefits and costs of vaccination
|
Dejonghe, P. |
|
1992 |
10 |
13 |
p. 936-939 4 p. |
artikel |
6 |
Biostatistical manual (BIOSTAT) for potency control and for evaluation of effectiveness of the WHO-EPI vaccines: software for personal computers
|
Lugosi, Laszlo |
|
1992 |
10 |
13 |
p. 961-963 3 p. |
artikel |
7 |
Calendar
|
|
|
1992 |
10 |
13 |
p. 966- 1 p. |
artikel |
8 |
Compositions containing protein antigen recognized by monoclonal antibody H23; for mamma carcinoma therapy; also vaccinia virus compositions for use in recombinant vaccine
|
|
|
1992 |
10 |
13 |
p. 965- 1 p. |
artikel |
9 |
Contribution to hepatitis B prevention
|
Stephenne, Jean |
|
1992 |
10 |
13 |
p. 900-903 4 p. |
artikel |
10 |
Contribution to rabies prevention
|
Sureau, P. |
|
1992 |
10 |
13 |
p. 896-899 4 p. |
artikel |
11 |
Editorial
|
|
|
1992 |
10 |
13 |
p. 891- 1 p. |
artikel |
12 |
EPI for the 1990s
|
Kim-Farley, R.J. |
|
1992 |
10 |
13 |
p. 940-948 9 p. |
artikel |
13 |
European vaccine manufacturers: present status and future trends
|
Baudrihaye, N. |
|
1992 |
10 |
13 |
p. 893-895 3 p. |
artikel |
14 |
Immunopotentiating reconstituted influenza virosomes (IRIVs) and other adjuvants for improved presentation of small antigens
|
Glück, Reinhard |
|
1992 |
10 |
13 |
p. 915-919 5 p. |
artikel |
15 |
Introduction
|
Furminger, I. |
|
1992 |
10 |
13 |
p. 892- 1 p. |
artikel |
16 |
New chronic fatigue immunodysfunction syndrome-associated CAV virus; used as a vaccine or for diagnosis, therapy and prophylaxis of infection; DNA probe, DNA primer construction; DNA sequence
|
|
|
1992 |
10 |
13 |
p. 964- 1 p. |
artikel |
17 |
New peptides common to Mycoplasma adhesion molecule and HIV proteins; Mycoplasma genitalium, Mycoplasma pneumoniae or Mycoplasma pirum adhesin, homologous with HIV virus glycoprotein, useful in vaccine against AIDS, Mycoplasma sp. infection, therapy, diagnosis
|
|
|
1992 |
10 |
13 |
p. 964- 1 p. |
artikel |
18 |
Nucleic acid encoding chicken anaemia virus; fowl-anaemia virus attenuation or antigen gene cloning and expression for use as recombinant vaccine or diagnostic agent
|
|
|
1992 |
10 |
13 |
p. 964- 1 p. |
artikel |
19 |
Preventive strategies against poliomyelitis
|
Swartz, T.A. |
|
1992 |
10 |
13 |
p. 904-908 5 p. |
artikel |
20 |
Recombinant baculovirus e.g. Autographa californica nuclear-polyhedrosis virus; used for pseudorabies virus glycoprotein-III gene cloning and expression in a Spodoptera frugiperda Sf21AE insect cell culture for use as a recombinant vaccine or diagnostic
|
|
|
1992 |
10 |
13 |
p. 965- 1 p. |
artikel |
21 |
Recombinant plasmid expressing secretory truncated glycoprotein of Varicella-zoster virus in mammal cell culture; use as vaccine for chicken pox or shingles, and use of monoclonal antibody in diagnosis
|
|
|
1992 |
10 |
13 |
p. 964- 1 p. |
artikel |
22 |
Strategies for the development of an antimalarial vaccine
|
Enders, Burkhard |
|
1992 |
10 |
13 |
p. 920-927 8 p. |
artikel |
23 |
The Children's Vaccine Initiative and vaccine supply: the role of the public sector
|
van Noort, R.B.J.C. |
|
1992 |
10 |
13 |
p. 909-910 2 p. |
artikel |
24 |
The cold chain from manufacturer to vaccinator: experiments and experiences
|
von Hedenström, Michael |
|
1992 |
10 |
13 |
p. 949-951 3 p. |
artikel |
25 |
The concept of herd immunity and the design of community-based immunization programmes
|
Anderson, Roy M. |
|
1992 |
10 |
13 |
p. 928-935 8 p. |
artikel |
26 |
The countries' point of view
|
Schatzmayr, Hermann G. |
|
1992 |
10 |
13 |
p. 954- 1 p. |
artikel |
27 |
Vaccine against equine-herpes virus; contains horse-herpes virus glycoprotein and/or lectin complex, or extracellular virion
|
|
|
1992 |
10 |
13 |
p. 965- 1 p. |
artikel |
28 |
Vaccine against varicella-zoster virus; recombinant vaccine or diagnostic agent preparation and DNA sequence
|
|
|
1992 |
10 |
13 |
p. 964- 1 p. |
artikel |